Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine/threonine-protein kinase SIK3, also known as Salt-Inducible Kinase 3 (SIK3), is a member of the AMP-activated protein kinase (AMPK) family. It functions as a serine/threonine kinase and plays key roles in cellular energy regulation, metabolism, circadian rhythm, and response to environmental stressors. Dysregulation of SIK3 has been observed in certain diseases including cancer. Its role in metabolic pathways makes it a potential therapeutic target for metabolic disorders, circadian rhythm disturbances, neurobiology-related conditions like sleep disorders, and possibly cancer therapy development pipelines are ongoing targeting this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine/threonine-protein kinase SIK3 (SIK3).